Abstract
Objective: To investigate the hypothalamic-pituitary-adrenal (HPA) axis via the insulintolerance test (ITT), standard-dose (250 µg) ACTH test (SDT) and low-dose (1 µg) ACTH test (LDT) in patients with ankylosing spondylitis (AS). DESIGN: The study group included 13 male patients with AS who were diagnosed according to the Modified New York criteria, and 8 healthy male subjects and was carried out at the Department of Physical Medicine and Rehabilitation, Erciyes University Medical School. ACTH stimulation tests were carried out by using 1 µg and 250 µg i.v. ACTH as a bolus injection, and blood samples were drawn at 0, 30 and 60 min. ITT was performed by using intravenous (i.v.) soluble insulin, and serum glucose and cortisol levels were measured before and after 30, 60, 90 and 120 min. All of the tests were performed consecutively with 3-day intervals, after an overnight fast. Results: There were no significant differences between the patients with AS (mean age 36.9±6.7 years) and the healthy subjects (mean age 37.4±5.7 years) in terms of age. The basal cortisol levels in the AS group measured during LDT, SDT and ITT (556±204 nmol/l; 524±169 nmol/l; 418±232 nmol/l, respectively) were comparable to the values of the control group (572±199 nmol/l; 520±182 nmol/l; 424±194 nmol/l, respectively). There were also no significant differences in peak cortisol responses between the two groups using LDT (patients 1025±339 nmol/l; controls 844±236 nmol/l), SDT (patients 1082±243 nmol/l; controls 1120±131 nmol/l) and ITT (patients 834±256 nmol/; controls 820±239 nmol/). Conclusion: In contrast with findings in other inflammatory diseases such as rheumatoid arthritis and polymyalgia rheumatica, the present data indicate that there is no apparent abnormality of the HPA axis activity in patients with AS.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Sieper J, Braun J, Rudwaleit M, Bonen A, Zink A, 2002 Ankylosing spondylitis: an overview. Ann Rheum Dis 61: Suppl 3: iii8–18.
Khan MA, 2002 Update on spondyloarthropathies. Ann Intern Med 136: 896–907.
Crofford LJ, 2002 The hypothalamic-pituitary-adrenal axis in the pathogenesis of rheumatic diseases. Endocrinol Metab Clin North Am 31: 1–13.
Dickstein G, Spigel D, Arad E, Shechner C, 1997 One microgram is the lowest ACTH dose to cause a maximal cortisol response. There is no diurnal variation of cortisol response to submaximal ACTH stimulation. Eur J Endocrinol 137: 172–175.
van der Linden S, Valkenburg HA, Cats A, 1984 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27: 361–368.
Gaillard RC, 1994 Neuroendocrine-immune system interactions. The immune-hypothalamo-pituitary-adrenal axis. Trends Endocrinol Metab 5: 303–309.
Gratacos J, Collado A, Filella X, et al, 1994 Serum cytokines (IL-6, TNF-α, IL-1β and INF-γ) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 10: 927–931.
Toussirot E, Lafforgue P, Boucraut J, Despieds P, Schiano A, Bernard D, 1994 Acquaviva PC, Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 receptor and soluble CD8 in seronegative spondyloarthropathies. Rheumatol Int 13: 175–180.
Morand EF, Leech M, 2001 Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis. Immunol Cell Biol 79: 395–399.
Chrousos GP, 1995 The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332: 1351–1362.
Demir H, Keleştimur F, Tunç M, Kirnap M, Özugul Y, 1999 Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scand J Rheumatol 28: 41–46.
Cutolo M, Foppiani L, Minuto F, 2002 Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Invest 25: Supp 10: 19–23.
Cutolo M, Straub RH, Foppiani L, et al, 2002 Adrenal gland hypofunction in active polymyalgia rheumatica. Effect of glucocorticoid treatment on adrenal hormones and interleukin 6. J Rheumatol 29: 748–756.
Demir H, Tanriverdi F, Ozogul N, et al, 2006 Evaluation of the hypothalamic-pituitary-adrenal axis in untreated patients with polymyalgia rheumatica and healthy controls. Scand J Rheumatol 35: 217–223.
Masi AT, 1992 Do sex hormones play a role in ankylosing spondylitis? Rheum Dis Clin North Am 18: 153–176.
Straub RH, Struharova S, Scholmerich J, Harle P, 2002 No alterations of serum levels of adrenal and gonadal hormones in patients with ankylosing spondylitis. Clin Exp Rheumatol 20: Suppl 28: S52–S59.
Arniaud D, Mattei JP, Boyer J, Roux H, 1998 Sex hormones in spondylarthropathies. A study in 57 patients. Rev Rhum Engl Ed 65: 21–26.
Hedman M, Nilsson E, de la Torre B, 1992 Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol 10: 25–30.
Imrich R, Rovensky J, Zlnay M, et al, 2004 Hypothalamic-pituitary-adrenal axis function in ankylosing spondylitis. Ann Rheum Dis 63: 671–674.
Grinspoon SK, Biller BM, 1994 Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 79: 923–931.
Kirnap M, Colak R, Eser C, Ozsoy O, Tutus A, Kelestimur F, 2001 A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome. Clin Endocrinol 55: 455–459.
Dokmetas HS, Colak R, Kelestimur F, Selcuklu A, Unluhizarci K, Bayram F, 2000 A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab 85: 3713–3719.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kirnap, M., Atmaca, H., Tanriverdi, F. et al. Hypothalamic-pituitary-adrenal axis in patients with ankylosing spondylitis. Hormones 7, 255–258 (2008). https://doi.org/10.14310/horm.2002.1206
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.14310/horm.2002.1206